The search for novel, biocompatible, and sustainable therapeutic agents has led to growing interest in plant-derived exosome nanoparticles (PDENs) as promising nanotherapeutics for animal and human health. These naturally occurring extracellular vesicles, isolated from edible plants, carry bioactive lipids, proteins, nucleic acids, and metabolites that may modulate immune responses and support disease management. Their unique properties, including high biocompatibility, low immunogenicity, oral stability, and scalable production, make them attractive candidates for veterinary and zoological applications. Recent studies suggest that PDENs from sources such as ginger, grapes, and broccoli can reduce inflammatory responses by downregulating pro-inflammatory cytokines and promoting tissue repair. They also show antimicrobial activity and may enhance the effectiveness of conventional antimicrobials by interfering with pathogen growth and biofilm formation. In animal health, these properties may be especially valuable for managing inflammation and infections that are increasingly influenced by climate change, such as heat stressassociated immune dysfunction, emerging infectious pressures, and environmental stress-related disease susceptibility. This highlights the therapeutic potential of PDENs as green nanotechnology platforms for future applications in veterinary medicine and zoological health. Their natural origin, multifunctional activity, and environmentally friendly profile make them a compelling candidate for innovative strategies to improve animal disease management under changing climatic conditions.